309 related articles for article (PubMed ID: 32997864)
21. Evaluation of a hydroquinone-free skin brightening product using in vitro inhibition of melanogenesis and clinical reduction of ultraviolet-induced hyperpigmentation.
Makino ET; Mehta RC; Banga A; Jain P; Sigler ML; Sonti S
J Drugs Dermatol; 2013 Mar; 12(3):s16-20. PubMed ID: 23545928
[TBL] [Abstract][Full Text] [Related]
22. Management of hyperpigmentation in darker racial ethnic groups.
Grimes PE
Semin Cutan Med Surg; 2009 Jun; 28(2):77-85. PubMed ID: 19608057
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the efficacy of cysteamine 5% cream and hydroquinone 4%/ascorbic acid 3% combination cream in the treatment of epidermal melasma.
Sepaskhah M; Karimi F; Bagheri Z; Kasraee B
J Cosmet Dermatol; 2022 Jul; 21(7):2871-2878. PubMed ID: 35510765
[TBL] [Abstract][Full Text] [Related]
24. Postinflammatory hyperpigmentation.
Taylor S; Grimes P; Lim J; Im S; Lui H
J Cutan Med Surg; 2009; 13(4):183-91. PubMed ID: 19706225
[TBL] [Abstract][Full Text] [Related]
25. The Safety and Efficacy of Treatment With a 1,927-nm Diode Laser With and Without Topical Hydroquinone for Facial Hyperpigmentation and Melasma in Darker Skin Types.
Vanaman Wilson MJ; Jones IT; Bolton J; Larsen L; Fabi SG
Dermatol Surg; 2018 Oct; 44(10):1304-1310. PubMed ID: 29659405
[TBL] [Abstract][Full Text] [Related]
26. Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study.
Grimes P; Callender V
Cutis; 2006 Jan; 77(1):45-50. PubMed ID: 16475496
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of cysteamine cream in the treatment of epidermal melasma, evaluating by Dermacatch as a new measurement method: a randomized double blind placebo controlled study.
Farshi S; Mansouri P; Kasraee B
J Dermatolog Treat; 2018 Mar; 29(2):182-189. PubMed ID: 28678558
[TBL] [Abstract][Full Text] [Related]
28. Hydroquinone therapy for post-inflammatory hyperpigmentation secondary to acne: not just prescribable by dermatologists.
Chandra M; Levitt J; Pensabene CA
Acta Derm Venereol; 2012 May; 92(3):232-5. PubMed ID: 22002814
[TBL] [Abstract][Full Text] [Related]
29. Effects of Topical Retinoids on Acne and Post-inflammatory Hyperpigmentation in Patients with Skin of Color: A Clinical Review and Implications for Practice.
Callender VD; Baldwin H; Cook-Bolden FE; Alexis AF; Stein Gold L; Guenin E
Am J Clin Dermatol; 2022 Jan; 23(1):69-81. PubMed ID: 34751927
[TBL] [Abstract][Full Text] [Related]
30. A focused review on acne-induced and aesthetic procedure-related postinflammatory hyperpigmentation in Asians.
Eimpunth S; Wanitphadeedecha R; Manuskiatti W
J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():7-18. PubMed ID: 23205540
[TBL] [Abstract][Full Text] [Related]
31. Considerations for treating acne in ethnic skin.
Callender VD
Cutis; 2005 Aug; 76(2 Suppl):19-23. PubMed ID: 16164153
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in the treatment of melasma.
Guevara IL; Pandya AG
Int J Dermatol; 2003 Dec; 42(12):966-72. PubMed ID: 14636195
[TBL] [Abstract][Full Text] [Related]
33. Postinflammatory hyperpigmentation: evolving combination treatment strategies.
Taylor SC; Burgess CM; Callender VD; Fu J; Rendon MI; Roberts WE; Shalita AR
Cutis; 2006 Aug; 78(2 Suppl 2):6-19. PubMed ID: 16977792
[TBL] [Abstract][Full Text] [Related]
34. Hydroquinone: myths and reality.
Searle T; Al-Niaimi F; Ali FR
Clin Exp Dermatol; 2021 Jun; 46(4):636-640. PubMed ID: 33159818
[TBL] [Abstract][Full Text] [Related]
35. Ethnic considerations in the treatment of Hispanic and Latin-American patients with hyperpigmentation.
Hexsel D; Arellano I; Rendon M
Br J Dermatol; 2006 Dec; 156 Suppl 1():7-12. PubMed ID: 17176299
[TBL] [Abstract][Full Text] [Related]
36. A Multi-Center, Randomized, Blinded Clinical Study Evaluating the Efficacy and Safety of a Novel Topical Product for Facial Dyschromia.
Wang J; Fabi S; Robinson D; Bajaj S; Geronemus R; Bell M; Widgerow A
J Drugs Dermatol; 2023 Apr; 22(4):333-338. PubMed ID: 37026875
[TBL] [Abstract][Full Text] [Related]
37. Effect of a Tranexamic Acid, Kojic Acid, and Niacinamide Containing Serum on Facial Dyschromia: A Clinical Evaluation.
Desai S; Ayres E; Bak H; Manco M; Lynch S; Raab S; Du A; Green D; Skobowiat C; Wangari-Talbot J; Zheng Q
J Drugs Dermatol; 2019 May; 18(5):454-459. PubMed ID: 31141852
[TBL] [Abstract][Full Text] [Related]
38. Topical agents used in the management of hyperpigmentation.
Halder RM; Richards GM
Skin Therapy Lett; 2004; 9(6):1-3. PubMed ID: 15334278
[TBL] [Abstract][Full Text] [Related]
39. In Vitro and In Vivo Efficacy and Tolerability of a Non-Hydroquinone, Multi-Action Skin Tone Correcting Cream.
Grimes PE; McDaniel DH; Wortzman M; Nelson D
J Drugs Dermatol; 2019 Jul; 18(7):642-648. PubMed ID: 31329402
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of salicylic acid peeling in comparison with topical tretinoin in the treatment of postinflammatory hyperpigmentation.
Mohamed Ali BM; Gheida SF; El Mahdy NA; Sadek SN
J Cosmet Dermatol; 2017 Mar; 16(1):52-60. PubMed ID: 27976510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
